Kevin Buehler - 27 Dec 2024 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Director
Signature: /s/ Dario Scimeca, Attorney-in-fact for Kevin Buehler
Issuer symbol: DTIL
Transactions as of: 27 Dec 2024
Net transactions value: +$21,082
Form type: 4
Filing time: 31 Dec 2024, 07:00:05 UTC
Previous filing: 06 Jun 2024
Next filing: 28 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Purchase	$21,082	+4,320	+98%	$4.88	8,712	27 Dec 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.73 to $4.94. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.73 to $4.94. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.